124 related articles for article (PubMed ID: 20093727)
1. Wnt up your mind - intervention strategies for S100A4-induced metastasis in colon cancer.
Sack U; Stein U
Gen Physiol Biophys; 2009; 28 Spec No Focus():F55-64. PubMed ID: 20093727
[TBL] [Abstract][Full Text] [Related]
2. Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.
Stein U; Arlt F; Smith J; Sack U; Herrmann P; Walther W; Lemm M; Fichtner I; Shoemaker RH; Schlag PM
Neoplasia; 2011 Feb; 13(2):131-44. PubMed ID: 21403839
[TBL] [Abstract][Full Text] [Related]
3. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
4. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
[TBL] [Abstract][Full Text] [Related]
5. S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.
Sack U; Walther W; Scudiero D; Selby M; Aumann J; Lemos C; Fichtner I; Schlag PM; Shoemaker RH; Stein U
Mol Biol Cell; 2011 Sep; 22(18):3344-54. PubMed ID: 21795396
[TBL] [Abstract][Full Text] [Related]
6. Niclosamide: an established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors.
Helfman DM
J Natl Cancer Inst; 2011 Jul; 103(13):991-2. PubMed ID: 21685360
[No Abstract] [Full Text] [Related]
7. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
8. Methylation-associated silencing of S100A4 expression in human epidermal cancers.
Li Y; Liu ZL; Zhang KL; Chen XY; Kong QY; Wu ML; Sun Y; Liu J; Li H
Exp Dermatol; 2009 Oct; 18(10):842-8. PubMed ID: 19703228
[TBL] [Abstract][Full Text] [Related]
9. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy.
Sherbet GV
Cancer Lett; 2009 Jul; 280(1):15-30. PubMed ID: 19059703
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.
Mencía N; Selga E; Rico I; de Almagro MC; Villalobos X; Ramirez S; Adan J; Hernández JL; Noé V; Ciudad CJ
BMC Cancer; 2010 Jun; 10():250. PubMed ID: 20515499
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
12. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429
[TBL] [Abstract][Full Text] [Related]
13. Wnt3a Promotes the Vasculogenic Mimicry Formation of Colon Cancer via Wnt/β-Catenin Signaling.
Qi L; Song W; Liu Z; Zhao X; Cao W; Sun B
Int J Mol Sci; 2015 Aug; 16(8):18564-79. PubMed ID: 26266404
[TBL] [Abstract][Full Text] [Related]
14. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
15. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
[TBL] [Abstract][Full Text] [Related]
17. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER
Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
19. The C-terminal region of S100A4 is important for its metastasis-inducing properties.
Zhang S; Wang G; Liu D; Bao Z; Fernig DG; Rudland PS; Barraclough R
Oncogene; 2005 Jun; 24(27):4401-11. PubMed ID: 15856021
[TBL] [Abstract][Full Text] [Related]
20. Smad4 restoration leads to a suppression of Wnt/beta-catenin signaling activity and migration capacity in human colon carcinoma cells.
Tian X; Du H; Fu X; Li K; Li A; Zhang Y
Biochem Biophys Res Commun; 2009 Mar; 380(3):478-83. PubMed ID: 19284991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
